News | Women's Health | August 01, 2017

The ACR-accredited breast imaging center installs Fujifilm's ASPIRE Cristalle, the digital FFDM system with DBT

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow

Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast imaging center based in Monterey, Cali., has installed Fujifilm’s ASPIRE Cristalle FFDM system with Digital Breast Tomosynthesis (DBT). The innovative 3-D breast imaging technology has been in use at the center since April.

“We are pleased and excited that The Mammography Center has selected Fujifilm’s ASPIRE Cristalle with DBT. It is especially gratifying to know that women in the Monterey area have access to advanced technology such as breast tomosynthesis in their own community,” said Rob Fabrizio, director of strategic marketing, digital radiography and women’s health, Fujifilm Medical Systems U.S.A., Inc. “We look forward to continuing to support The Mammography Center of Monterey in their efforts to educate women and build awareness about the benefits of 3-D mammography with both clinicians and patients.”

In business for 28 years, The Mammography Center of Monterey was seeking to expand its offerings with the latest mammography technology. The facility decided to make an investment in the latest advanced technology versus staying with a traditional 2-D system. After evaluating competitive breast tomosynthesis units—and speaking with both a technologist and a radiologist familiar with the ASPIRE Cristalle—the facility opted for Fujifilm’s ASPIRE Cristalle.

“Radiologists at the center are impressed with the technology and their ability to clearly see details, especially in images of dense breast tissue,” said Mary Lou Catania, RN, founder and president, The Mammography Center of Monterey.

According to Catania, since the center began using ASPIRE Cristalle with DBT, recall rates have dropped and in fact, there have been no patients recalled due to dense breast images.

Catania also stated that the Fujifilm system is easy-to-use, comfortable for patients, and affordable. She credits the company with a smooth installation and excellent training, saying technologists quickly got up to speed on the ASPIRE Cristalle and were able to rapidly get back on track performing a backlog of patient exams.

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow to optimize patient dose while maximizing image quality.

For more information: www.fujimed.com

 


Related Content

News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
Subscribe Now